Highly Improved Synthesis of (+)-Aureol via (-)-Neoavarone and (-)-Neo­avarol, by Employing Salcomine Oxidation and Acid-Induced Rearrangement/Cyclization Strategy

Akiyuki  Suzuki; Mari  Nakatani; Masahiko  Nakamura; Keiko  Kawaguchi; Munenori  Inoue; Tadashi  Katoh

doi:10.1055/s-2003-37130

RSS-Feed abonnieren

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000083.xml

Teilen / Bookmarken

Facebook Linkedin Weibo

PDF herunterladen

Synlett 2003(3): 0329-0332
DOI: 10.1055/s-2003-37130

LETTER

Highly Improved Synthesis of (+)-Aureol via (-)-Neoavarone and (-)-Neoavarol, by Employing Salcomine Oxidation and Acid-Induced Rearrangement/Cyclization Strategy

Akiyuki Suzuki^b, Mari Nakatani^a, Masahiko Nakamura^c, Keiko Kawaguchi^b, Munenori Inoue^a, Tadashi Katoh*^a,c
^a Sagami Chemical Research Center, Hayakawa 2743-1, Ayase, Kanagawa 252-1193, Japan
Fax: +81(467)774113; e-Mail: takatoh@alles.or.jp;
^b Department of Chemistry, Kitasato University, Kitasato, Sagamihara, Kanagawa 228-0829, Japan
^c Department of Electronic Chemistry, Tokyo Institute of Technology, Nagatsuta, Yokohama 226-8502, Japan

Weitere Informationen

Publikationsverlauf

Received 6 January 2003
Publikationsdatum:
07. Februar 2003 (online)

Abstract
Volltext
Referenzen

Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

A short and efficient synthesis of (+)-aureol (1), a structurally novel and biologically important marine natural product, was achieved starting with readily available (+)-Wieland-Miescher ketone analogue 7 via (-)-neoavarone (10) and (-)-neoavarol (11). The method features salcomine oxidation of the phenol derivative 9 to deliver 10 and BF₃·OEt₂-induced rearrangement/cyclization reaction of 11 to produce 1 as the crucial steps. The improved biomimetic synthesis required only 9 steps and proceeds in 31% overall yield.

Key words

aureol - neoavarone - neoavarol - marine natural product - rearrangement/cyclization reaction

References

For recent excellent reports on the clerodane diterpenoids and related compounds including marine natural products, see:
1a Faulkner DJ. Nat. Prod. Rep. 2002, 19: 1

Thieme Connect Suche in Google Scholar
1b Capon RJ. Eur. J. Org. Chem. 2001, 633

Thieme Connect
1c Tokoroyama T. Synthesis 2000, 611

Thieme Connect
1d Capon RJ. In Studies in Natural Products Chemistry Vol. 15: . Elsevier Science B.V.; Amsterdam: 1995. p.289-326

Thieme Connect Suche in Google Scholar
2 Djura P. Stierle DB. Sullivan B. Faulkner DJ. Arnold E. Clardy J. J. Org. Chem. 1980, 45: 1435

Crossref Suche in Google Scholar
3 Ciminiello P. Dell’Aversano C. Fattorusso E. Magno S. Pansini M. J. Nat. Prod. 2000, 63: 263

Crossref Suche in Google Scholar
4 Longley RE. McConnell OJ. Essich E. Harmody D. J. Nat. Prod. 1993, 56: 915

Crossref Suche in Google Scholar
5 Wright AE, Cross SS, Burres NS, and Koehn F. inventors; Harbor Branch Oceanographics Institution Inc. PCT WO 9112250A1. August 22,
6 Nakamura M. Suzuki A. Nakatani M. Fuchikami T. Inoue M. Katoh T. Tetrahedron Lett. 2002, 43: 6929

Crossref Suche in Google Scholar
7 Kawano H. Itoh M. Katoh T. Terashima S. Tetrahedron Lett. 1997, 38: 7769

Crossref Suche in Google Scholar
8 Hagiwara H. Uda H. J. Org. Chem. 1988, 53: 2308

Crossref Suche in Google Scholar
9 Iguchi K. Sahashi A. Kohno J. Yamada Y. Chem. Pharm. Bull. 1990, 38: 1121

Suche in Google Scholar
The total synthesis of avarone (i)and avarol (ii, Figure 2), which correspond to the C4 endo-olefinic isomers of neoavarone(10) and neoavarol(11), respectively, have been previously achieved by several research groups, see:
10a Ling T. Poupon E. Rueden EJ. Kim SH. Theodorakis EA. J. Am. Chem. Soc. 2002, 124: 12261

Crossref Suche in Google Scholar
10b Ling T. Xiang AX. Theodorakis EA. Angew. Chem. Int. Ed. 1999, 38: 3089

Crossref Suche in Google Scholar
10c Locke EP. Hecht SM. Chem. Commun. 1996, 2717

Crossref
10d An J. Wiemer DF. J. Org. Chem. 1996, 61: 8775

Crossref Suche in Google Scholar
10e Sarma AS. Chattopadhyay P. J. Org. Chem. 1982, 47: 1727

Crossref Suche in Google Scholar
11 The starting material 8 was prepared from (+)-Wieland-Miescher ketone analogue 7 (>99% ee) according to the following Scheme 4. For further details, see: Nakatani M. Nakamura M. Suzuki A. Inoue M. Katoh T. Org. Lett. 2002, 4: 4483

Crossref PubMed Suche in Google Scholar
12a Taishi T. Takechi S. Mori S. Tetrahedron Lett. 1998, 39: 4347

Crossref Suche in Google Scholar
12b Aristoff PA. Harrison AW. Huber AM. Tetrahedron Lett. 1984, 25: 3955

Crossref Suche in Google Scholar
12c Welch SC. Pao ASCP. Tetrahedron Lett. 1977, 505

Crossref
12d Feutrill GI. Mirrington RN. Aust. J. Chem. 1972, 25: 1719

Crossref Suche in Google Scholar
12e Bartlett PA. Johnson WS. Tetrahedron Lett. 1970, 4459

Crossref
14a Katoh T. Nakatani M. Shikita S. Sampe R. Ishiwata A. Ohmori O. Nakamura M. Terashima S. Org. Lett. 2001, 3: 2701

Suche in Google Scholar
14b Miyata F. Yoshida S. Yamori T. Katoh T. Heterocycles 2001, 54: 619

Suche in Google Scholar
14c Saito N. Obara Y. Aihara T. Harada S. Shida Y. Kubo A. Tetrahedron 1994, 50: 3915

Suche in Google Scholar
14d Yoshida K. Nakajima S. Ohnuma T. Ban Y. Shibasaki M. Aoe K. Date T. J. Org. Chem. 1988, 53: 5355

Suche in Google Scholar
14e Wakamatsu T. Nishi T. Ohnuma T. Ban Y. Synth. Commun. 1984, 14: 1167

Suche in Google Scholar
The reducing reagent Na₂S₂O₄ has been widely used for the conversion of sesquiterpenoidal quinones to the corresponding hydroquinones. For recent examples, see: ref.^10c,10d. For additional examples, see:
16a Kawai N. Fujibayashi Y. Kuwabara S. Takao K. Ijuin Y. Kobayashi S. Tetrahedron 2000, 56: 6467

Crossref Suche in Google Scholar
16b Watson AT. Park K. Wiemer DF. J. Org. Chem. 1995, 60: 5102

Crossref Suche in Google Scholar
16c Harada N. Sugioka T. Ando Y. Uda H. Kuriki T. J. Am. Chem. Soc. 1988, 110: 8483

Crossref Suche in Google Scholar

13

Spectral Data for 9: ¹H NMR (500 MHz, CDCl₃): δ = 0.87 (s, 3 H), 0.98-1.03 (m, 1 H), 1.02 (d, J = 6.0 Hz, 3 H), 1.06 (s, 3 H), 1.19-1.44 (m, 5 H), 1.44-1.49 (m, 1 H), 1.51-1.62 (m, 1 H), 1.87-1.94 (m, 1 H), 2.02-2.12 (m, 2 H), 2.30-2.39 (m, 1 H), 2.56 (d, J = 14.4 Hz, 1 H), 2.68 (d, J = 14.4 Hz, 1 H), 4.35-4.39 (m, 1 H), 4.40-4.44 (m, 1 H), 4.61-4.65 (br s, 1 H), 6.68-6.73 (m, 1 H), 6.79-6.85 (m, 1 H), 7.00-7.09 (m, 2 H). ¹³C NMR (125 MHz, CDCl₃): δ = 17.6, 17.7, 20.6, 23.2, 27.8, 28.2, 33.0, 36.3, 36.5, 37.4, 40.2, 42.0, 48.1, 102.7, 115.5, 120.2, 125.1, 127.2, 132.9, 154.5, 160.1. IR (KBr): 3547, 3439, 2957, 2920, 2858, 1720, 1631, 1587, 1452, 1383, 1332, 1255, 1170, 1122, 1086, 1049, 1022, 991, 927, 891, 864, 754, 611, 530 cm^-1. MS (CI): m/z = 299 [(M + H)⁺]. Anal. Calcd for C₂₁H₃₀O: C, 84.51; H, 10.13. Found: C, 84.63; H, 10.33.

15

Procedure for the Conversion of the Phenolic Compound 9 to (-)-Neoavarone 10. N,N-Bis(salicylidene)ethylenedi-iminocobalt(II) (55 mg, 0.17 mmol) was added to a stirred solution of 9 (101 mg, 0.34 mmol) in dry DMF (10 mL) at r.t. The suspension was stirred under an oxygen atmosphere (O₂ balloon) for 7 h at r.t. The mixture was concentrated in vacuo to afford a residue, which was purified by column chromatography (hexane-ethyl acetate, 20:1) to give 10 (96 mg, 91%) as a yellow solid. Recrystallization from diethyl ether-hexane afforded yellow prisms. ¹H NMR (500 MHz, CDCl₃): δ = 0.76 (dd, J = 12.1, 2.0 Hz, 1 H), 0.86 (s, 3 H), 0.94 (d, J = 6.6 Hz, 3 H), 1.05 (s, 3 H), 1.10-1.21 (m, 2 H), 1.32-1.38 (m, 1 H), 1.42-1.46 (m, 2 H), 1.47-1.57 (m, 2 H), 1.85-1.91 (m, 2 H), 2.06-2.12 (m, 1 H), 2.27-2.35 (m, 1 H), 2.40 (dd, J = 13.5, 0.8 Hz, 1 H), 2.57 (d, J = 13.5 Hz, 1 H), 4.44 (t, J = 1.4, 1 H), 4.46 (t, J = 1.7 Hz, 1 H), 6.45-6.47 (m, 1 H), 6.70 (dd, J = 10.0, 2.4, 1 H), 6.74 (d, J = 10.0 Hz, 1 H). ¹³C NMR (125 MHz, CDCl₃): δ = 16.8, 17.6, 20.6, 22.7, 27.4, 28.1, 32.8, 35.3, 36.7, 37.2, 40.3, 43.0, 49.3, 103.2, 135.9, 136.0, 137.1, 147.3, 159.6, 187.2, 187.4. IR (KBr): 3445, 2978, 2920, 2861, 1655, 1597, 1451, 1387, 1354, 1292, 1071, 897 cm^-1. HRMS (FAB): m/z calcd for C₂₁H₂₉O₂ [(M + H)⁺]: 313.2167. Found: 313.2195.

17

Spectral Data for 11: ¹H NMR (500 MHz, CDCl₃): δ = 0.86 (s, 3 H), 1.01 (d, J = 6.0 Hz, 3 H), 0.98-1.02 (m, 1 H), 1.06 (s, 3 H), 1.24-1.36 (m, 2 H), 1.38-1.44 (m, 3 H), 1.46-1.51 (m, 1 H), 1.51-1.61 (m, 1 H), 1.87-1.92 (m, 1 H), 1.99-2.06 (m, 1 H), 2.07-2.12 (m, 1 H), 2.34 (tt, J = 8.3, 1.6 Hz, 1 H), 2.51 (d, J = 14.3 Hz, 1 H), 2.63 (d, J = 14.3, 1 H), 4.35 (s, 2 H), 4.40 (br s, 1 H), 4.43 (t, J = 1.8, 1 H), 6.52 (d, J = 2.8 Hz, 1 H), 6.55 (dd, J = 8.4, 2.9 Hz, 1 H), 6.59 (d, J = 8.4 Hz, 1 H). ¹³C NMR (125 MHz, CDCl₃): δ = 17.6, 17.6, 20.6, 23.2, 27.7, 28.3, 33.0, 36.3, 36.5, 37.5, 40.3, 42.1, 48.2, 102.9, 113.9, 116.2, 119.4, 126.5, 148.6, 148.7, 160.0. IR (KBr): 3252, 2971, 2919, 2857, 1632, 1503, 1453, 1402, 1188, 1154, 891, 810, 752 cm^-1. HRMS (FAB): m/z calcd for C₂₁H₃₁O₂ [(M + H)⁺]: 315.2324. Found: 315.2344.

18

Procedure for the conversion of (-)-neoavarol (11) to(+)-aureol (1). BF₃ ·OEt₂ (148 µL, 1.1 mmol) was added to a stirred solution of 11 (35 mg, 0.1 mmol) in CH₂Cl₂ (20 mL) at -45 °C. The mixture was gradually warmed up to -5 °C over 4 h. The reaction was quenched with sat. aq NaHCO₃ (0.5 mL), and the mixture was extracted with CH₂Cl₂ (3 × 5 mL). The combined extracts were washed with brine, and then dried over Na₂SO₄. Concentration of the solvent in vacuo afforded a residue, which was purified by column chromatography (hexane-ethyl acetate, 10:1) to give 1 (33 mg, 93%) as a white solid. ¹H NMR (500 MHz, CDCl₃): δ = 0.78 (s, 3 H), 0.92 (s, 3 H), 1.06 (s, 3 H), 1.11 (d, J = 7.6 Hz, 3 H), 1.16-1.21 (m, 1 H), 1.32-1.38 (m, 1 H), 1.41-1.50 (m, 3 H), 1.52-1.61 (m, 1 H), 1.63-1.72 (m, 2 H), 1.74-1.87 (m, 2 H), 1.96 (d, J = 17.4 Hz, 1 H), 1.99-2.11 (m, 2 H), 3.37 (d, J = 17.4 Hz, 1 H), 4.29 (br s, 1 H), 6.49 (d, J = 2.7 Hz, 1 H), 6.54-6.63 (m, 2 H). ¹³C NMR (125 MHz, CDCl₃): δ = 17.3, 18.4, 20.2, 22.2, 27.9, 29.3, 29.8, 31.9, 33.8, 33.9, 37.4, 38.1, 39.3, 44.0, 82.4, 114.0, 115.1, 117.3, 122.2, 145.8, 148.3. IR (KBr): 17.3, 18.4, 20.2, 22.2, 27.9, 29.3, 29.8, 31.9, 33.8, 33.9, 37.4, 38.1, 39.3, 44.0, 82.4, 114.0, 115.1, 117.3, 122.2, 145.8, 148.3 cm^-1. HRMS (EI): m/z calcd for C₂₁H₃₀O₂ (M⁺): 314.2246. Found: 314.2241.

19

In our previous synthesis of (+)-aureol (1), [6] the cis-fused decalin system 6 [(+)-arenarol] was used as the substrate for the key acid-induced rearrangement/cyclization reaction, while in the present study the trans-fused decalin system 11 [(-)-neoavarol] is employed instead of 6. In these rearrangement/cyclization process, we believe that the same carbocation intermediate such as II would be generated in situ from 6 and 11, respectively, leading ultimately to the formation of (+)-aureol (1). And furthermore, we have already reported a similar carbocation-mediated domino process that is initiated by Lewis acid-induced epoxide-opening, followed by consecutive suprafacial methanide and hydride migrations. For further details, see the literature cited in ref. 11.